Demographic And Socioeconomic Determinants

Demographic and Socioeconomic Determinants

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Resident Lebanese Population('000)	3,962	4,036	4,104	4,168	4,231	4,292	4,356	4,421	3,864*	3,910*	3,944*	3,966*	3,989*	3,989*	4,044*
Number of Registered Lebanese Births(MOI)	91,795	97,887	90,167	86,950	88,704	85,453	88,996	90,647	89,772	86,179	74,049***	68,130***	62,868***	66,866***	65,209***
Number of Registered Lebanese Deaths(MOI)	21,441	23,257	22,792	23,414	25,117	25,275	24,617	25,847	25,096	24,950	28,637***	34,725***	29,455***	26,284***	26,715***
Number of Hospital Live Births**(VDO-MoPH)	-	77,341	79,605	89,379	105,348	110,416	114,627	124,597	127,143	116,254	106,535	96,156	97,232	94,153	88,316
Number of Hospital Lebanese Live Births* (HMS-MoPH)*							71,016	69,380	68,518	65,274	57,459	53,297	50,756	51,113	50,600
Number of Births (Lebanese adolescent women aged 15-19 years)	-	-	-	-	-	-	-	2,771	2,659	2,322	1,767	1,692	1,704	1,524	1,469
Total Fertility Rate (Lebanese women aged 15-49 years)	-	-	-	-	-	-	-	1.8
Number of Hospital Deaths ** (HMS-MoPH)								18,145	18,226	18,747	21,197	27,583	21,939	20,210	22,957
Number of Hospital Lebanese Deaths ** (HMS-MoPH)								15,574	15,412	16,084	18,224	23,747	18,509	16,981	19,801

*Lebanese Population Estimate based on latest CAS survey results (Labor Force and Household Living Conditions Survey - LFHLCS 2018)
**Including Non-Lebanese
*** as on 02/05/2025

...

All

ATC	Name	B/G	Ingredients	Form	Price
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 20mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,037,446 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,067,011 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	1,067,011 L.L
L01FY02	OPDUALAG	BioTech	Nivolumab - 240mg/20ml, Relatlimab - 80mg/20ml	Injectable solution	764,283,658 L.L
S01CA01	OPTIDEX T	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml	Drops suspension	266,081 L.L
S02AA30	OTOCOL	G	Chloramphenicol - 50mg/ml, Benzocaine - 50mg/ml	Drops	163,949 L.L
S02DA01	OTIPAX	B	Lidocaine HCl - 1g/100g, Phenazone - 4g/100g	Drops	233,829 L.L
N01BB58	ORABLOC	G	Articaine HCl - 4%, Epinephrine (tartrate) - 1/100.000	Injectable solution	2,308,721 L.L
A12AX	OSTRONG	G	Vitamin D3 - 500IU, Calcium hydrogen phosphate - 600mg	Tablet	435,149 L.L
C10BA05	OTOREZA	G	Atorvastatin - 10mg, Ezetimibe - 10mg	Tablet, film coated	908,438 L.L
C10BA05	OTOREZA 10/10	G	Atorvastatin - 10mg, Ezetimibe - 10mg	Tablet, film coated	454,219 L.L
C10BA05	OTOREZA 10MG/20MG	G	Atorvastatin - 20mg, Ezetimibe - 10mg	Tablet, film coated	561,726 L.L
C10BA05	OTOREZA 10MG/40MG	G	Atorvastatin - 40mg, Ezetimibe - 10mg	Tablet, film coated	1,144,954 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l	Injectable emulsion	4,711,512 L.L
B05BA10	OLIMEL N9	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Azote - 9g/l	Injectable emulsion	5,630,028 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 54mmol/l, Chloride - 45mmol/l, Azote - 9g/l	Injectable emulsion	3,550,432 L.L
B05BA10	OLIMEL N7E	B	Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 35mmol/l, Potassium - 30mmol/l, Magnesium - 4mmol/l, Calcium - 3.5mmol/l, Phosphate - 15mmol/l, Acetate - 45mmol/l, Chloride - 45mmol/l, Azote - 7g/l	Injectable emulsion	3,534,306 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg	Tablet, film coated	981,005 L.L
B05BA10	OLIMEL N7E	B	Glucose solution - 35%, Amino acids solution - 11.1%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 89mmol/2l, Chloride - 90mmol/2l, Azote - 14g/2l	Injectable emulsion	4,711,512 L.L
C09DA08	OLMENOR PLUS	G	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg	Tablet, film coated	653,107 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	981,005 L.L
C09DA08	OLMENOR PLUS	G	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	653,107 L.L
R01AB06	OTRIVIN DUAL RELIEF	B	Xylometazoline HCl - 0.5mg/ml, Ipratropium bromide - 0.6mg/ml	Solution	563,070 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg	Tablet, film coated	946,065 L.L
C09DA08	OLMENOR PLUS	G	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg	Tablet, film coated	628,918 L.L
C09DA08	OLMETEC PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	946,065 L.L
C09DA08	OLMENOR PLUS	G	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	628,918 L.L
G01AX	OVUMIX	G	Metronidazole - 300mg, Miconazole - 100mg, Neomycin (sulfate) - 48.8mg, Gotu Kola - 15mg, Polymixin sulfate - 4.4mg	Suppository	395,090 L.L
L04AA32	OTEZLA	B	Apremilast - 4x10mg- 4x20mg- 19x30mg	Tablet, film coated	34,751,325 L.L
R06AX	ORADUS BETA	G	Desloratadine - 1mg/ml, Betamethasone - 0.05mg/ml	Solution	639,925 L.L

...